Hillstream BioPharma, Inc. (NASDAQ:HILS – Get Free Report)’s stock price rose 0.9% during mid-day trading on Friday . The stock traded as high as $2.18 and last traded at $2.15. Approximately 46,244 shares traded hands during trading, a decline of 97% from the average daily volume of 1,388,685 shares. The stock had previously closed at $2.13.
Hillstream BioPharma Price Performance
The company has a market cap of $36.26 million, a PE ratio of -2.86 and a beta of 3.08. The stock has a fifty day moving average price of $2.04 and a 200-day moving average price of $2.55.
Hillstream BioPharma Company Profile
Hillstream BioPharma, Inc, a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors.
Featured Stories
- Five stocks we like better than Hillstream BioPharma
- How is Compound Interest Calculated?
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- Using the MarketBeat Dividend Tax Calculator
- These 3 Quirky ETFs May Be Strong Plays in 2025
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
Receive News & Ratings for Hillstream BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hillstream BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
